These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20347778)

  • 1. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK; Reddy K; Balakumar P
    Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S; Mahadevan N; Balakumar P
    Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
    Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
    Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
    Balakumar P; Chakkarwar VA; Singh M
    Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M; Chopra K
    Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
    Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
    J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
    Calkin AC; Giunti S; Jandeleit-Dahm KA; Allen TJ; Cooper ME; Thomas MC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2399-405. PubMed ID: 16720596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
    Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
    J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
    Das J; Sil PC
    Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
    Anjaneyulu M; Chopra K
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):244-8. PubMed ID: 15053821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers.
    Wagner JA; Larson PJ; Weiss S; Miller JL; Doebber TW; Wu MS; Moller DE; Gottesdiener KM
    J Clin Pharmacol; 2005 May; 45(5):504-13. PubMed ID: 15831773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol.
    Kuhad A; Sachdeva AK; Chopra K
    J Agric Food Chem; 2009 Jul; 57(14):6123-8. PubMed ID: 19601660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats.
    Baraka A; AbdelGawad H
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):175-81. PubMed ID: 20133494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.